Economic implications of reducing caesarean section rates - Analysis of two health systems.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 06 2019
accepted: 07 01 2020
entrez: 30 7 2020
pubmed: 30 7 2020
medline: 25 9 2020
Statut: epublish

Résumé

Caesarean section (CS) rates throughout Europe have risen significantly over the last two decades. As well as being an important clinical issue, these changes in mode of birth may have substantial resource implications. Policy initiatives to curb this rise have had to contend with the multiplier effect of women who had a CS for their first birth having a greater likelihood of requiring one during subsequent births, thus making it difficult to decrease CS rates in the short term. Our study examines the long-term resource implications of reducing CS rates among first-time mothers, as well as improving rates of vaginal birth after caesarean section (VBAC), among an annual cohort of women over the course of their most active childbearing years (18 to 44 years) in two public health systems in Europe. We found that the economic benefit of improvements in these two outcomes is considerable, with the net present value of the savings associated with a five-percentage-point change in nulliparous CS rates and VBAC rates being €1.1million and £9.8million per annual cohort of 18-year-olds in Ireland and England/Wales, respectively. Reductions in CS rates among first-time mothers are associated with a greater payoff than comparable increases in VBAC rates. The net present value of achieving CS rates comparable to those currently observed in the best performing Scandinavian countries was €3.5M and £23.0M per annual cohort in Ireland and England/Wales, respectively.

Identifiants

pubmed: 32722668
doi: 10.1371/journal.pone.0228309
pii: PONE-D-19-17170
pmc: PMC7386590
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0228309

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Lancet. 2018 Oct 13;392(10155):1341-1348
pubmed: 30322584
Lancet. 2018 Oct 13;392(10155):1358-1368
pubmed: 30322586
BMJ. 2015 Nov 04;351:h5516
pubmed: 26538498
Lancet. 2018 Oct 13;392(10155):1349-1357
pubmed: 30322585
Obstet Gynecol. 2013 Dec;122(6):1169-75
pubmed: 24201683
Eur J Obstet Gynecol Reprod Biol. 2019 Apr;235:42-48
pubmed: 30784826

Auteurs

Patrick S Moran (PS)

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Charles Normand (C)

Centre for Health Policy and Management, Trinity College Dublin, Dublin, Ireland.
Cicely Saunders Institute, King's College London, London, United Kingdom.

Patricia Gillen (P)

School of Nursing Research, Institute of Nursing and Health Research, Ulster University, Coleraine, United Kingdom.

Francesca Wuytack (F)

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Michael Turner (M)

School Of Medicine, University College Dublin, Dublin, Ireland.

Cecily Begley (C)

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Deirdre Daly (D)

School of Nursing and Midwifery, Trinity College Dublin, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH